Public health, innovation, intellectual property and trade

Areas of work

Assistive technology is a key element of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property.

Health R&D encompasses the WHO strategy for research on health as well as elements related to the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG)

Intellectual property and trade
WHO has a long standing mandate to work on the impact of intellectual property and trade on public health.

Technology transfer to developing countries can enable recipient countries to produce the product locally and may result in increased access to the product and improved health.

Monitoring and reporting on the progress of implementation of elements of the Global Strategy is vital to ensure success.



Public health, innovation, intellectual property and trade

Dr Suzanne Hill
Director, EMP
Essential Medicines and Health Products (EMP)

Dr Marie-Paule Kieny
Assistant Director-General, HIS
Health Systems and Innovation (HIS)